- Home
- LICN vs EVGN Comparison
LICN vs EVGN Comparison
Compare LICN & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- EVGN
- Stock Information
- Founded
- LICN 2004
- EVGN 1999
- Country
- LICN China
- EVGN Israel
- Employees
- LICN N/A
- EVGN N/A
- Industry
- LICN
- EVGN Agricultural Chemicals
- Sector
- LICN
- EVGN Industrials
- Exchange
- LICN Nasdaq
- EVGN Nasdaq
- Market Cap
- LICN 8.7M
- EVGN 9.7M
- IPO Year
- LICN 2023
- EVGN N/A
- Fundamental
- Price
- LICN $0.07
- EVGN $1.42
- Analyst Decision
- LICN
- EVGN Strong Buy
- Analyst Count
- LICN 0
- EVGN 1
- Target Price
- LICN N/A
- EVGN $12.00
- AVG Volume (30 Days)
- LICN 30.4M
- EVGN 21.1K
- Earning Date
- LICN 12-31-2024
- EVGN 03-06-2025
- Dividend Yield
- LICN N/A
- EVGN N/A
- EPS Growth
- LICN 36.90
- EVGN N/A
- EPS
- LICN 0.28
- EVGN N/A
- Revenue
- LICN $41,929,000.00
- EVGN $7,478,000.00
- Revenue This Year
- LICN N/A
- EVGN $90.35
- Revenue Next Year
- LICN N/A
- EVGN $38.71
- P/E Ratio
- LICN $0.28
- EVGN N/A
- Revenue Growth
- LICN 24.86
- EVGN 30.69
- 52 Week Low
- LICN $0.06
- EVGN $1.20
- 52 Week High
- LICN $2.44
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- LICN 29.78
- EVGN 42.28
- Support Level
- LICN $0.06
- EVGN $1.44
- Resistance Level
- LICN $0.08
- EVGN $1.55
- Average True Range (ATR)
- LICN 0.01
- EVGN 0.09
- MACD
- LICN 0.02
- EVGN -0.01
- Stochastic Oscillator
- LICN 56.39
- EVGN 17.41
About LICN Lichen China Limited
Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.